| Literature DB >> 17870543 |
Jie Li1, Fang-I Chiang, Hsiao-Nung Chen, Cheng-Wei Tom Chang.
Abstract
Continuing from our ongoing effort in modifying aminoglycoside antibiotics with the goal of counteracting drug resistant bacteria, we have further derivatized pyranmycin, a neomycin class aminoglycoside antibiotic, with modifications at O-6 and N-1 positions. The revealed SAR results demonstrated that the antibacterial activity of pyranmycin can be modulated by different acylic substituents at O-6. Among these results, the 6-O-aminoethyl derivative, JT050, showed effective activity against resistant strain Escherichia coli (pTZ19U-3) and E. coli (pSF815), which provides insight into further structural modifications.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17870543 PMCID: PMC2692305 DOI: 10.1016/j.bmc.2007.08.059
Source DB: PubMed Journal: Bioorg Med Chem ISSN: 0968-0896 Impact factor: 3.641